Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2025-03-19 00:00:00 ET · period of report 2025-03-16 · accession 0001415889-25-008614 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-19 | 2025-03-16 | KNSA | Patel Sanj K | COB, CEO, Dir | F - Tax | $22.61 | -2,004 | 84.1K | -2% | -$45.3K |
| D | 2025-03-19 | 2025-03-16 | KNSA | Patel Sanj K | COB, CEO, Dir | M - OptEx | — | +6,569 | 86.1K | +8% | — |
| D | 2025-03-19 | 2025-03-16 | KNSA | Patel Sanj K | COB, CEO, Dir | M - OptEx | $0.00 | -6,569 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Share | 2025-03-16 | F | D | 2,004 | $22.61 | 84,116 | D | — | — | |
| 2 | Common | Class A Ordinary Share | 2025-03-16 | M | A | 6,569 | — | 86,120 | D | — | — | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. |
| 3 | Derivative | Restricted Share Unit | 2025-03-16 | M | D | 6,569 | $0.00 | 0 | D | — · — to — | 6,569 Class A Ordinary Share | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. (F2) The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, March 16, 2021. |